Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07222722 · ClinicalTrials.gov registry record · NA
NIRS Monitoring in the NICU and AKI
A NA study of Acute Kidney Injury (AKI) and Postnatal AKI, sponsored by NYU Langone Health.
- Recruiting
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT07222722: Recruiting NA study of Acute Kidney Injury (AKI) and Postnatal AKI, sponsored by NYU Langone Health.
NCT07222722 is a NA study of Acute Kidney Injury (AKI) and Postnatal AKI that is actively recruiting participants, run by NYU Langone Health. The registered enrollment target is 100 participants, below the 4,613-participant average among 4 other Acute Kidney Injury (AKI) trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07222722, a NA study of Acute Kidney Injury (AKI) and Postnatal AKI, is actively recruiting participants, sponsored by NYU Langone Health.
- RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary objective of this study is to describe the pattern of renal tissue oxygen saturation (SrSO2) using near-infrared spectroscopy (NIRS) in premature infants \<30 weeks gestational age. The secondary objective of this study is to evaluate prenatal and postnatal risk factors for acute kidney injury (AKI) in premature infants \<30 weeks gestational age. The investigators will also compare various rates of complications including death, length-of-stay, and prolonged duration of mechanical ventilation, among others.
Primary Outcome
NIRS values measured as renal tissue oxygen saturation (SrSO2); measured continuously over first 7 days of life.
Conditions Studied
Interventions
- DEVICE NIRS Monitoring
Study Locations (1)
New York
- NYU Langone Health - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2025-11 |
| Est. Completion | 2026-04-01 |
| Phase | NA |
What NCT07222722 shows while recruiting
NCT07222722 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 4,613-participant average among 4 other Acute Kidney Injury (AKI) trials with a reported enrollment target (98% lower).
The record links to 2 conditions, with Acute Kidney Injury (AKI) appearing as the primary indexed condition, and to 1 intervention - of which NIRS Monitoring is the first listed.
NCT07222722 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT07222722 about?
NCT07222722 is a clinical study titled "NIRS Monitoring in the NICU and AKI". The primary objective of this study is to describe the pattern of renal tissue oxygen saturation (SrSO2) using near-infrared spectroscopy (NIRS) in premature infants \<30 weeks gestational age. The secondary objective of this study is to evaluate prenatal and postnatal risk factors for acute kidney ...
What is the current status of trial NCT07222722?
This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2025-11. Estimated completion is 2026-04-01.
What conditions does trial NCT07222722 study?
This clinical trial studies the following conditions: Acute Kidney Injury (AKI), Postnatal AKI.
What interventions are being tested in trial NCT07222722?
The interventions under investigation include: NIRS Monitoring (DEVICE).
Who is sponsoring clinical trial NCT07222722?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07222722 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Kidney Injury (AKI)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Safety Evaluation of Prismocitrate 18 in Patients Receiving CRRT
RECRUITING · Phase 3
-
The Choice of Vasopressor to Prevent Postoperative Acute Kidney Injury After Major Non-Cardiac Surgery
RECRUITING · Phase 4
-
Study to Evaluate the Efficacy of ASP1128 (MA-0217) in Subjects at Risk for Acute Kidney Injury (AKI) Following Coronary Artery Bypass Graft (CABG) and/or Valve Surgery
COMPLETED · Phase 2
-
Retrospective Analysis of Prismaflex HF20 Set Versus ppCRRT Registry
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia